PHAXIAM Therapeutics S.A. (PHXM) — Cash Flow Reinvestment Rate

Latest as of December 2012: 0.08x

PHAXIAM Therapeutics S.A. (PHXM) has a Cash Flow Reinvestment Rate of 0.08x as of December 2012, reinvesting €48.40K (capex €48.40K ) from operating cash flow of €621.40K. Explore reinvestment intensity of PHAXIAM Therapeutics S.A. to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.08x

(Capex + Investments) / Operating CF

Total Reinvested

€48.40K

Capex + Investments

Operating Cash Flow

€621.40K

EUR

Capital Expenditures

€48.40K

EUR

PHAXIAM Therapeutics S.A. Cash Flow Reinvestment Rate (2012–2012)

Historical reinvestment intensity for PHAXIAM Therapeutics S.A. across 1 annual periods. Also explore PHAXIAM Therapeutics S.A. assets under control for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for PHAXIAM Therapeutics S.A. (2012–2012)

Year-by-year capital reinvestment analysis for PHAXIAM Therapeutics S.A.. For live market cap and broader valuation context, see market value of PHAXIAM Therapeutics S.A..

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2012	0.08x	€52.50K	€621.40K	€52.50K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow